Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

European Innovation Council · Running

ELVIS ELEM Virtual Heart Populations for Supercomputers

Coordinator
Elem Biotech SL, Spain
Runs
1 March 2023 to 31 August 2025
Status
Running
EU funding
€2.5m
Total cost
€3.5m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190134524

What the project is doing

In the project's own words, from its summary on CORDIS.

ELEMs V.Heart is a supercomputer-based platform to perform massive in-silico clinical trials on populations of digital avatars generated through a database of real medical data, to study the outcomes of different therapies. It assesses the safety and efficacy of novel therapeutics, devices or drugs, by computing thousands of scenarios. Current capability covers classic or leadless pacing and cardiac pumps and cardiac safety of drugs.

Our plan is to add new therapies whilst increasing the range of our patented virtual population technology. V.Heart generates unparalleled medical insights and new evidence for biomedical professionals whilst shortening time to market and reducing business and patient risks. It narrows the scope for animal testing and tapers real human trials by evaluating clinical study endpoints much faster and earlier in the development process.

Eventually, digital avatars become a Digital Twin of any given patient used as a predictive tool for precision medicine.

Topics

Who is involved

OrganisationCityCountryRole
Elem Biotech SLBarcelonaSpainCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI